to develop your career and gain broader financial accounting experience. Accountabilities Month End Accounts to Trial Balance... duties as designated by senior management. The Candidate: Accounting Technician or Part qualified accountant Minimum 3...
to ensure consistent financial reporting. We are dynamic accounting professionals who continue to strive for professional... contributor to projects geared toward automation and accounting for new entities. About the Role Become a member of the...
Job Description: Senior Vice President, Fund/ Client Accounting Manager At BNY, our culture empowers you to grow... a future team member for the role of Senior Vice President, Fund/ Client Accounting Manager to join our Private Equity, Ireland...
and timely posting of all accounting data using SAGE 50 Accounting. Assist Senior Management in developing robust stock... requirements. Engage in daily SAGE 50 accounting tasks: Accounts Payable & Receivables, bank reconciliations, VAT processing...
Chile, home to the world’s biggest lithium reserves, is confident that investors will compete for licenses to drill new deposits even amid a worsening global glut that’s squeezing the battery-metal industry. Continue Reading »
Gold Prices Today: Gold of 99.9 and 99.5 per cent purity grew ₹2,320 each in the last seven trading sessions. However, silver prices declined ₹500 to ₹93,500 per kg from the previous close Continue Reading »
At 11:57 a.m. ET, the Dow Jones Industrial Average rose 0.58 per cent, the S&P 500 gained 0.14 per cent, the Nasdaq Composite lost 0.19 per cent Continue Reading »
Expert view: Mohit Khanna anticipates the Union Budget 2025 will prioritize youth, women, the poor, and farmers, with increased spending on rural housing, irrigation, and employment-linked incentives. Continue Reading »
HPCL Q3 Results: The state-owned OMC's revenue from operations in the third quarter of current fiscal rose to ₹1.10 lakh crore led by better marketing margins. Continue Reading »
Dr Reddy's Laboratories reported a 2% YoY increase in PAT to ₹1,413.3 crore for Q3 2024, driven by a 16% rise in revenue to ₹8,358.6 crore. The company invested ₹6.7 billion in R&D, focusing on complex generics and biosimilars. Continue Reading »